l.boateng
Submits third-party assay reports on material purchased directly. Based in Lyon.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.84%
n=10
Suppliers covered
7
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041562 | Triptorelin | QSC | QSC-2607-C6970 | Janoshik | 2026-Q3 | 99.92 | 2.82 | 89.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043107 | Tirzepatide | KP | KP-2608-D5921 | Janoshik | 2026-Q3 | 98.93 | 5.64 | 91.7 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-043079 | Tirzepatide | KP | KP-2605-E6030 | Kestrel | 2026-Q2 | 98.91 | 4.18 | 89.6 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-018736 | Semaglutide | QSC | QSC-2412-F7396 | PeptideMeter | 2025-Q2 | 98.95 | 3.32 | 95.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020842 | CJC-1295 with DAC | SGN | SGN-2408-K1629 | Janoshik | 2025-Q1 | 98.78 | 3.61 | 96.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004651 | Retatrutide | TFC | TFC-2409-H7264 | Janoshik | 2024-Q4 | 97.62 | 4.50 | 96.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005485 | Tirzepatide | BCH | BCH-2407-F6722 | Janoshik | 2024-Q4 | 96.93 | 5.02 | 91.3 | Buyer-sourced | 2 | FAIL |
| AX-2024-004144 | Retatrutide | WWB | WWB-2408-X2078 | VendorInvestigate | 2024-Q4 | 99.19 | 5.93 | 105.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005406 | Semax | WXT | WXT-2402-W3946 | Medutest | 2024-Q2 | 98.61 | 7.19 | — | Supplier-supplied | 1 | FAIL |
| AX-2024-005404 | Semax | WXT | WXT-2402-W3946 | Medutest | 2024-Q2 | 98.20 | 6.77 | 92.6 | Supplier-supplied | 0 | FAIL |